ANDA 85037, held by Epic Pharma LLC. Lidocaine Hydrochloride.
As of Nov 16, 2026, ANDA 85037 (Lidocaine Hydrochloride), held by Epic Pharma LLC, was first approved by FDA on Jul 29, 1976, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 29, 1976 | Original application | Approved | None posted |
| Lidocaine Hydrochloride1% · injectable;injection | Lidocaine Hydrochloride | Discontinued |
| Lidocaine Hydrochloride2% · injectable;injection | Lidocaine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters